Sort
25,944 grants matching “neurodegeneration”
Robust Mendelian Randomization Framework with Multi-Omics Data for Alzheimer's Disease and Related Dementias
$554,980Zhonghua Liu · Columbia University Health Sciences · R01 · FY2024 · AG
Sex divergence and cell specificity of age-related hippocampal DNA modifications
$554,739Willard M Freeman · Oklahoma Medical Research Foundation · R01 · FY2021 · AG
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
$554,697Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2024 · AI
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
$554,697Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2023 · AI
Targeting neuroinflammation in AD with novel CX3CR1 agonists
$554,644Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Mechanisms of Polyglutamine Neurodegeneration
$554,514Henry L Paulson · University Of Michigan At Ann Arbor · R01 · FY2018 · NS
Mitochondrial Fusion and Division
$554,447Hiromi Sesaki · Johns Hopkins University · R01 · FY2014 · GM
Molecular Mechanisms of Axonal Transport
$554,282Scott Thomas Brady · University Of Illinois At Chicago · R56 · FY2011 · NS
Accelerated non-atherosclerotic brain arterial aging relationship to Alzheimer's disease
$554,226Jose Gutierrez · Columbia University Health Sciences · R01 · FY2019 · AG
Allosteric regulation of SIRT1 by a PACS-2 and DBC1 regulatory hub
$554,136Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · DK
MR & Optical Diagnosis of Mitochondrial Metabolism and Dysfunction
$553,953Kevin E Conley · University Of Washington · R01 · FY2008 · AR
Mechanisms of alpha-synuclein mediated inflammation in multiple system atrophy
$553,842Ashley N Harms · University Of Alabama At Birmingham · R56 · FY2024 · NS
Protective potential of functionally enhanced AlphaA-crystallin in neurodegeneration
$553,828Patrice E. Fort · University Of Michigan At Ann Arbor · R01 · FY2022 · EY
Cell Death Pathways in Glaucomatous Neurodegeneration
$553,716Richard T Libby · University Of Rochester · R01 · FY2022 · EY
Cell Death Pathways in Glaucomatous Neurodegeneration
$553,716Richard T Libby · University Of Rochester · R01 · FY2021 · EY
Defining the Effects of Astrocytic TDP-43 Dysregulation on Hippocampal Function
$553,484Anna Goldshmidt Orr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
A Systems Approach to Stress Biology and Proteostasis Networks
$553,005Richard I. Morimoto · Northwestern University · R01 · FY2012 · GM
Vanderbilt Interdisciplinary Training Program in Alzheimer's Disease
$552,847Angela L. Jefferson · Vanderbilt University · T32 · FY2024 · AG
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease
$552,677Theodore R Holman · University Of California Santa Cruz · R01 · FY2019 · AG
A Unified Atlas of Dynamic tRNA Function
$552,582Todd Michael Lowe · University Of California Santa Cruz · R01 · FY2019 · HG
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$552,574Elizabeth Head · University Of California-Irvine · R01 · FY2020 · AG
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach
$552,444Thomas O Obisesan · Howard University · R01 · FY2016 · AG
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach
$552,444Thomas O Obisesan · Howard University · R01 · FY2018 · AG
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach
$552,444Thomas O Obisesan · Howard University · R01 · FY2017 · AG
Prediction of Psychosis in Alzheimer Disease
$552,334Robert A Sweet · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AG